2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Open accessAbstract
national Society for Heart and Lung Transplantation; d Representing the European League Against Rheumatism; and e Representing the European Society of Radiology.ESC entities having participated in the development of this document: ESC Associations: Acute Cardiovascular Care Association (ACCA), European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA).ESC Councils: Council for Cardiology Practice (CCP), Council on Cardiovascular Nursing and Allied Professions (CCNAP), Council on Cardiovascular Primary Care (CCPC).ESC Working Groups: Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Grown-up Congenital Heart Disease, Pulmonary Circulation and Right Ventricular Function, Valvular Heart Disease.The content of these European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines has been published for personal and educational use only.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Section 6 identifies pulmonary arterial hypertension (PAH) as group 1. But Section 4.1, “Epidemiology and risk factors” (page unavailable), says left-heart disease (group 2) is believed to be the most common cause of pulmonary hypertension, contrary to the claim that group 1 is most common. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe paper says the ESC/ERS pulmonary hypertension model uses a multiparametric assessment and avoids nonmodifiable criteria and variable weighting.
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284) Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Section 6.2.4 calls for a multidimensional, comprehensive assessment, and section 6.2.5 says overall assessment should guide decisions when variables fall into different risk categories. The claim that the model avoids any nonmodifiable criteria is too absolute: both sections say age, sex, and other factors not affected by therapy can modify risk. The passages do not explicitly specify whether variables receive numerical weights. (LLM, conf=0.85)
Experimental — accuracy not yet measuredUnlike REVEAL, the ESC/ERS model avoids non-modifiable criteria and does not weight variables by relative importance.
“Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Table 13 and §§6.2.4–6.2.5 present risk categories using clinical and physiological measures without assigning numerical weights to the variables. They discuss age, sex, underlying disease and comorbidities as additional influences on risk, rather than criteria in Table 13. Our copy does not establish the claimed contrast with REVEAL’s criteria or weighting. (LLM, conf=0.82)
Experimental — accuracy not yet measuredTransplantation may be necessary if prostacyclin treatment is required for an appropriate intervention, there is accompanying liver or renal failure, or severe hemoptysis is present.
“transplantation may be necessary if prostacyclin treatment is required for an appropriate intervention, there is accompanying liver or renal failure, or severe hemoptysis is present [3,59-62]”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Section 6.3.8 supports considering lung transplantation for patients with pulmonary arterial hypertension who respond inadequately to medical therapy. It does not identify a need for prostacyclin treatment, liver or renal failure, or severe haemoptysis as the stated triggers; section 6.3.10.2 instead suggests bronchial artery embolization for severe haemoptysis. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measuredGroup 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Section 6.3.8 (page unavailable) recommends considering lung transplantation for PAH after an inadequate response to treatment. Section 9.2 (page unavailable) says patients with suspected PAH alongside lung disease may follow PAH recommendations, but limits this to a particular clinical phenotype; it does not recommend transplantation for group 3 patients generally. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Group 2, with decreased left ventricular function, is not an indication for transplantation.
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Section 7.6.2 identifies group 2 pulmonary hypertension as due to left heart disease and says it occurs with heart failure with reduced or preserved ejection fraction. Section 6.3.8 discusses transplantation for pulmonary arterial hypertension, but does not say that group 2 disease with decreased left ventricular function is not an indication for transplantation. No page numbers are available in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThe two most frequently used pulmonary arterial hypertension risk assessment models are REVEAL 2.0 and the 2015 ESC/ERS model.
“The two most frequently used risk assessment models are the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL) 2.0 and the 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) model.(283, 284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The ESC/ERS model uses multi-parametric comprehensive analysis of clinical variables for risk assessment in pulmonary arterial hypertension.
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 and 2015 European Society of Cardiology/European Respiratory Society.
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
Self-citationLang, R., Badano, L., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F., Foster, E., Goldstein, S., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 10,093 · see citing works
Self-citationLang, R. M., Badano, L. P., Mor‐Avi, V., Afilalo, J., Armstrong, A. D. C., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,449 · see citing works
Self-citationRudski, L., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,080 · see citing works
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
Self-citationInterpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945 · see citing works
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191 · see citing works
Self-citationGuidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,841 · see citing works
Self-citationGuidelines on the management of valvular heart disease
Vahanian, A. S., Baumgartner, H., Bax, J. J., Butchart, E., Dion, R., Filippatos, G. S., Flachskampf, F., Hall, R., Iung, B., Kasprzak, J. D., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,579 · see citing works
Self-citationGuidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559 · see citing works
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., KEOGH, A. M., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,718 · see citing works
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. Μ., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,688 · see citing works
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D. B., Fleming, T. R., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,466 · see citing works
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S., Gladwin, M. T., Jing, Z., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,090 · see citing works
Self-citationPrimary Pulmonary Hypertension
Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027 · see citing works
Pulmonary Arterial Hypertension in France
Humbert, M. J. C., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 1,994 · see citing works
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G. M., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,895 · see citing works
Self-citationExpression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R. D., Shennib, H., Kimura, S., Masaki, Τ., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,838 · see citing works
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828 · see citing works
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., HIGENBOTTAM, T. W., Naeije, R., Rubin, L. J., Nikkho, S. M., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,778 · see citing works
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R. P., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,763 · see citing works
Self-citationAbraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744 · see citing works
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,558 · see citing works
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547 · see citing works
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,529 · see citing works
Self-citationSimonneau, G., Barst, R. J., Galiè, N., Naeije, R., Rich, S., Bourge, R. C., KEOGH, A. M., Oudiz, R. J., Frost, A., Blackburn, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,440 · see citing works
Self-citationMacitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Адзерихо, И. Э., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Jing, Z., Brun, F. L., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,439 · see citing works
Self-citationRiociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H. A., D’Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,393 · see citing works
Self-citationLong-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M. J. C., Nunès, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,374 · see citing works
Self-citationGiaid, A., & Saleh, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,366 · see citing works
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346 · see citing works
Self-citationGhio, S., Gavazzi, A., Campana, C., Inserra, C. A., Klersy, C., Sebastiani, R., Arbustini, E., Recusani, F., & Tavazzi, L. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01102-5 · Cited by 1,285 · see citing works
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M. J. C., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,244 · see citing works
Self-citationSurvival in Primary Pulmonary Hypertension
McLaughlin, V. V., Shillington, A. C., & Rich, S. (2002) · Circulation · doi:10.1161/01.cir.0000029100.82385.58 · Cited by 1,217 · see citing works
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,186 · see citing works
Self-citationChronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,152 · see citing works
Self-citationDiagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Sánchez, M. Á. G., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M. D., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138 · see citing works
Self-citationExercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. P., & Redfield, M. M. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.930701 · Cited by 1,119 · see citing works
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,096 · see citing works
Self-citationTricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Forfia, P. R., Fisher, M. R., Mathai, S. C., Housten-Harris, T., Hemnes, A. R., Borlaug, B. A., Chamera, E. H., Corretti, M. C., Champion, H. C., Abraham, T. P., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-547oc · Cited by 1,091 · see citing works
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Galiè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,077 · see citing works
Self-citationAccuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
Fisher, M. R., Forfia, P. R., Chamera, E. H., Housten-Harris, T., Champion, H. C., Girgis, R. E., Corretti, M. C., & Hassoun, P. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1691oc · Cited by 1,075 · see citing works
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,071 · see citing works
Self-citationPrimary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V., Steele, P. M., Edwards, W. D., et al. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,069 · see citing works
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Pepke‐Żaba, J., Delcroix, M., Lang, I. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015008 · Cited by 1,063 · see citing works
Self-citationSelexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R. N., Chin, K., Frey, A., Gaine, S., Galiè, N., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,059 · see citing works
Self-citationPulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Kovács, G., Berghold, A., Scheidl, S. J., & Olschewski, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00145608 · Cited by 1,053 · see citing works
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jaïs, X., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,016 · see citing works
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunès, H., Brillet, P., Delaval, P.-E., Devouassoux, G., Tillie‐Leblond, I., Israël‐Biet, D., Court‐Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,001 · see citing works
Diagnosis and differential assessment of pulmonary arterial hypertension
Barst, R. J., McGoon, M. D., Torbicki, A., Sitbon, O., Krowka, M. J., Olschewski, H., & Gaine, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.032 · Cited by 992 · see citing works
Self-citationIncreased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D., Levy, R. D., Černáček, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980 · see citing works
Galiè, N., Rubin, L., Hoeper, M. M., Jansa, P., Al‐Hiti, H., Meyer, G. M. B., Chiossi, E., Kusic‐Pajic, A., & Simonneau, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60919-8 · Cited by 917 · see citing works
Self-citationEchocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A. A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 908 · see citing works
(2006) · Springer eBooks · doi:10.1007/3-540-29832-0_1355 · Cited by 885 · see citing works
Diller, G.-P., Dimopoulos, K., Okonko, D., Li, W., Babu-Narayan, S. V., Broberg, C. S., Johansson, B., Bouzas, B., Mullen, M. J., Poole-Wilson, P. A., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.529800 · Cited by 878 · see citing works
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 875 · see citing works
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · CHEST Journal · doi:10.1378/chest.129.3.746 · Cited by 873 · see citing works
van de Veerdonk, M. C., Kind, T., Marcus, J. T., Mauritz, G.-J., Heymans, M. W., Bogaard, H.-J., Boonstra, A., Marques, K. M. J., Westerhof, N., & Vonk-Noordegraaf, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.068 · Cited by 846 · see citing works
Self-citationBosentan Therapy in Patients With Eisenmenger Syndrome
Galiè, N., Beghetti, M., Gatzoulis, M. Α., Granton, J. T., Berger, R. M. F., Lauer, A., Chiossi, E., & Landzberg, M. J. (2006) · Circulation · doi:10.1161/circulationaha.106.630715 · Cited by 844 · see citing works
Self-citationEvidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Coghlan, G., Denton, C. P., Grünig, E., Bonderman, D., Distler, O., Khanna, D., Müller‐Ladner, U., Pope, J. E., Vonk, M. C., Doelberg, M., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203301 · Cited by 832 · see citing works
Self-citationEchocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Raymond, R. J., Hinderliter, A. L., Willis, P. W., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01744-8 · Cited by 828 · see citing works
Humbert, M. J. C., Monti, G., Brénot, F., Sitbon, O., Portier, A., Grangeot‐Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Émilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 793 · see citing works
Self-citationAn epidemiological study of pulmonary arterial hypertension
Peacock, A., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 793 · see citing works
Self-citationChronic Thromboembolic Pulmonary Hypertension
Fedullo, P. F., Auger, W. R., Kerr, K. M., & Rubin, L. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010902 · Cited by 766 · see citing works
Mukerjee, D., George, D. S., Coleiro, B., Knight, C., Denton, C. P., Davar, J., Black, C. M., & Coghlan, G. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1088 · Cited by 758 · see citing works
Self-citationvan Wolferen, S. A., Marcus, J. T., Boonstra, A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl477 · Cited by 757 · see citing works
HACHULLA, E., Gressin, V., Guillevin, L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21433 · Cited by 747 · see citing works
Mayer, E., Jenkins, D. P., Lindner, J., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.11.024 · Cited by 736 · see citing works
Mereles, D., Ehlken, N., Kreuscher, S., Ghofrani, S., Hoeper, M. M., Halank, M., Meyer, F. J., Karger, G., Buss, J., Juenger, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.618397 · Cited by 724 · see citing works
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schött, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 711 · see citing works
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
Rubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 701 · see citing works
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M. J. C., Sitbon, O., Yaici, A., Montani, D., O’Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 675 · see citing works
Self-citationPulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H. C., Coghlan, G., Cottin, V., Marco, T. D., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 674 · see citing works
Self-citationUpdated Treatment Algorithm of Pulmonary Arterial Hypertension
Galiè, N., Corris, P. A., Frost, A., Girgis, R. E., Granton, J. T., Jing, Z., Klepetko, W., McGoon, M. D., McLaughlin, V. V., Preston, I. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.031 · Cited by 668 · see citing works
Self-citationPulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., BOURDIN, A. A., Bouvaist, H., Canuet, M., Pison, C. M., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 658 · see citing works
Self-citationA meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Galiè, N., Mañes, A., Negro, L., Palazzini, M., Reggiani, M. L. B., & Branzi, A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp022 · Cited by 648 · see citing works
Self-citationGaliè, N., Humbert, M. J. C., Vachiéry, J., Vizza, C. D., Kneußl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 645 · see citing works
Self-citationCombination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M. J. C., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 638 · see citing works
Self-citationPulmonary Hypertension Due to Left Heart Diseases
Vachiéry, J., Adir, Y., Barberà, J. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.033 · Cited by 637 · see citing works
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634 · see citing works
Beraprost therapy for pulmonary arterial hypertension
Barst, R. J., McGoon, M. D., McLaughlin, V. V., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00463-7 · Cited by 632 · see citing works
Christie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · see citing works
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 624 · see citing works
Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension
Sun, X., Hansen, J. E., Oudiz, R. J., & Wasserman, K. (2001) · Circulation · doi:10.1161/hc2901.093198 · Cited by 624 · see citing works
Genetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R. D., Grünig, E., Aldred, M. A., Geraci, M. W., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 614 · see citing works
Self-citationSimonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 613 · see citing works
Self-citationHoeper, M. M., Lee, S. H., Voswinckel, R., Palazzini, M., Jaïs, X., Marinelli, A., Barst, R. J., Ghofrani, H. A., Jing, Z., Opitz, C. F., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.061 · Cited by 611 · see citing works
Self-citationMizoguchi, H., Ogawa, A., Munemasa, M., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.971077 · Cited by 609 · see citing works
Krowka, M. J., Plevak, D. J., Findlay, J. Y., Rosen, C. B. B., Wiesner, R. H., & Krom, R. A. F. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.6356 · Cited by 608 · see citing works
Madani, M. M., Auger, W. R., Pretorius, V. G., et al. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.04.004 · Cited by 607 · see citing works
Survival with first-line bosentan in patients with primary pulmonary hypertension
McLaughlin, V. V., Sitbon, O., Badesch, D. B., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00054804 · Cited by 605 · see citing works
Tunariu, N., Gibbs, S., Win, Z. T., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.039438 · Cited by 601 · see citing works
Self-citationExtracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
Fuehner, T., Kuehn, C., Hadem, J., Wiesner, O., Gottlieb, J., Tudorache, I., Olsson, K. M., Greer, M., Sommer, W., Welte, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1599oc · Cited by 596 · see citing works
Self-citationAssessment of Survival in Patients With Primary Pulmonary Hypertension
Wensel, R., Opitz, C. F., Anker, S. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022687.18568.2a · Cited by 570 · see citing works
Self-citationAddition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
McLaughlin, V. V., Benza, R. L., Rubin, L. J., Channick, R. N., Voswinckel, R., Tapson, V. F., Robbins, I. M., Olschewski, H., Rubenfire, M., & Seeger, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.027 · Cited by 564 · see citing works
Taylor, D. O., Edwards, L. B., Boucek, M. M., Trulock, E. P., Waltz, D. A., Keck, B. M., & Hertz, M. I. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.05.002 · Cited by 558 · see citing works
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Jaïs, X., D’Armini, A. M., Jansa, P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.059 · Cited by 551 · see citing works
Self-citationBiomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 546 · see citing works
Pediatric Pulmonary Hypertension
Ivy, D. D., Abman, S. H., Barst, R. J., Berger, R. M. F., Bonnet, D., Fleming, T. R., Haworth, S. G., Raj, J. U., Rosenzweig, E. B., Schulze‐Neick, I., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.028 · Cited by 543 · see citing works
Self-citationBalloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension
Feinstein, J. A., Goldhaber, S. Z., Lock, J. E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.10 · Cited by 532 · see citing works
Pulmonary Arterial Hypertension
McGoon, M. D., Benza, R. L., Subías, P. E., Jiang, X., Miller, D. P., Peacock, A. J., Pepke‐Żaba, J., Pulido, T., Rich, S., Rosenkranz, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.023 · Cited by 526 · see citing works
Self-citationPulmonary veno-occlusive disease
Montani, D., Lau, E., Dorfmüller, P., Girerd, B., Jaïs, X., Savale, L., Perros, F., Nossent, E. J., Garcia, G., Parent, F., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00026-2016 · Cited by 523 · see citing works
Self-citationAmbrisentan therapy for pulmonary arterial hypertension.
Galiè, N., Badesch, D., Oudiz, R., Simonneau, G., Mcgoon, M., Keogh, A., Frost, A., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 522 · see citing works
Self-citationEisenmenger syndrome. Factors relating to deterioration and death
Daliento, L., Somerville, J., Presbitero, P., Menti, L., Prever, S. B., Rizzoli, G., & Stone, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1046 · Cited by 522 · see citing works
Chronic Thromboembolic Pulmonary Hypertension
Kim, N. H., Delcroix, M., Jenkins, D. P., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.024 · Cited by 520 · see citing works
The endothelin system in pulmonary arterial hypertension
Galiè, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 517 · see citing works
Self-citationPrognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
Oswald–Mammosser, M., Weitzenblum, E., Quoix, É., Moser, G., Chaouat, A., Charpentier, C., & Kessler, R. (1995) · CHEST Journal · doi:10.1378/chest.107.5.1193 · Cited by 516 · see citing works
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M. F., Beghetti, M., Humpl, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 509 · see citing works
Self-citationLong-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects
Rosenzweig, E. B., Kerstein, D., & Barst, R. J. (1999) · Circulation · doi:10.1161/01.cir.99.14.1858 · Cited by 507 · see citing works
Portopulmonary hypertension and hepatopulmonary syndrome
Hoeper, M. M., Krowka, M. J., & Strassburg, C. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16107-2 · Cited by 501 · see citing works
Self-citationThabut, G., Dauriat, G., Stern, J. B., Logeart, D., Levy, A., Marrash-Chahla, R., & Mal, H. (2005) · CHEST Journal · doi:10.1378/chest.127.5.1531 · Cited by 494 · see citing works
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Thenappan, T., Shah, S. J., Rich, S., Tian, L., Archer, S. L., & Gomberg‐Maitland, M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00072709 · Cited by 491 · see citing works
Clinical efficacy of sildenafil in primary pulmonary hypertension
Sastry, B. K. S., Narasimhan, C., Reddy, N. K., & Raju, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.056 · Cited by 487 · see citing works
Pulmonary Hypertension Due to Left Heart Disease
Guazzi, M., & Borlaug, B. A. (2012) · Circulation · doi:10.1161/circulationaha.111.085761 · Cited by 483 · see citing works
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Pavec, J. L., Prévôt, G., Mal, H., Humbert, M. J. C., Simonneau, G., Cordier, J. F., & GERM“O”P (2009) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 480 · see citing works
Self-citationA Novel Channelopathy in Pulmonary Arterial Hypertension
Ma, L., Roman‐Campos, D., Austin, E. D., Eyries, M., Sampson, K. S., Soubrier, F., Germain, M., Trégouët, D., Borczuk, A., Rosenzweig, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211097 · Cited by 473 · see citing works
Self-citationGoal-oriented treatment and combination therapy for pulmonary arterial hypertension
Hoeper, M. M., Markevych, I., Spiekerkoetter, E. F., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00075305 · Cited by 469 · see citing works
Self-citationWeitzenblum, E., Sautegeau, A., Ehrhart, M., et al. (1985) · American Review of Respiratory Disease · doi:10.1164/arrd.1985.131.4.493 · Cited by 464 · see citing works
Lang, I. M., Pesavento, R., Bonderman, D., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00049312 · Cited by 457 · see citing works
Self-citationPrevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
Sitbon, O., Lascoux‐Combe, C., Delfraissy, J., Yéni, P., Raffi, F., de Zuttere, D., Gressin, V., Clerson, P., Séréni, D., & Simonneau, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-541oc · Cited by 457 · see citing works
Self-citationChronic thromboembolic pulmonary hypertension
Dartevelle, P., Fadel, É., Mussot, S., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00079704 · Cited by 451 · see citing works
Fine, N. M., Chen, L., Bastiansen, P. M., Frantz, R. P., Pellikka, P. A., Oh, J. K., & Kane, G. C. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000640 · Cited by 448 · see citing works
Hopkins, W. E., Ochoa, L. L., Richardson, G., et al. (1996) · PubMed · Cited by 447 · see citing works
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Eyries, M., Montani, D., Girerd, B., Perret, C., Leroy, A., Lonjou, C., Chelghoum, N., Coulet, F., Bonnet, D., Dorfmüller, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2844 · Cited by 445 · see citing works
Self-citationVasodilator Therapy for Primary Pulmonary Hypertension in Children
Barst, R. J., Maislin, G., & Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1197 · Cited by 429 · see citing works
Fijałkowska, A., Kurzyna, M., Torbicki, A., et al. (2006) · CHEST Journal · doi:10.1378/chest.129.5.1313 · Cited by 416 · see citing works
Self-citationSurvival in pulmonary hypertension in Spain: insights from the Spanish registry
Subías, P. E., Blanco, I., López‐Meseguer, M., López-Guarch, C. J., Román, A., Morales, P., Castillo‐Palma, M. J., Segovia, J., Gómez‐Sánchez, M. Á., & Barberà, J. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00101211 · Cited by 414 · see citing works
Self-citationPulmonary Vascular Disease in Adults With Congenital Heart Disease
Diller, G., & Gatzoulis, M. A. (2007) · Circulation · doi:10.1161/circulationaha.105.592386 · Cited by 407 · see citing works
Kielstein, J. T., Impraim, B., Simmel, S., Bode‐Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H. G., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 400 · see citing works
Self-citationTan, R. T., Kuzo, R. S., Goodman, L. R., et al. (1998) · CHEST Journal · doi:10.1378/chest.113.5.1250 · Cited by 400 · see citing works
Secondary Pulmonary Hypertension in Chronic Heart Failure
Moraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 400 · see citing works
Jaïs, X., Launay, D., Yaïci, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 399 · see citing works
Rubens, C., Ewert, R., Halank, M., et al. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1562 · Cited by 392 · see citing works
Price, L., Wort, S. J., Finney, S. J., Marino, P. S., & Brett, S. J. (2010) · Critical Care · doi:10.1186/cc9264 · Cited by 390 · see citing works
Portopulmonary hypertension: Results from a 10-year screening algorithm
Krowka, M. J., Swanson, K. L., Frantz, R. P., et al. (2006) · Hepatology · doi:10.1002/hep.21431 · Cited by 386 · see citing works
Humbert, M., Yaïci, A., de Groote, P., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30541 · Cited by 382 · see citing works
Self-citationKataoka, M., Inami, T., Hayashida, K., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.971390 · Cited by 382 · see citing works
Engelfriet, P. M., Duffels, M. G. J., Møller, T., Boersma, E. H., Tijssen, J. G. P., Thaulow, E., Gatzoulis, M. A., & Mulder, B. J. M. (2006) · Heart · doi:10.1136/hrt.2006.098848 · Cited by 381 · see citing works
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 381 · see citing works
Self-citationSurvival in Childhood Pulmonary Arterial Hypertension
Barst, R. J., McGoon, M. D., Elliott, C. G., Foreman, A. J., Miller, D. P., & Ivy, D. D. (2011) · Circulation · doi:10.1161/circulationaha.111.026591 · Cited by 380 · see citing works
Tapson, V. F., Torres, F., Kermeen, F. D., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2212 · Cited by 378 · see citing works
Anticoagulation and Survival in Pulmonary Arterial Hypertension
Olsson, K. M., Delcroix, M., Ghofrani, H. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 373 · see citing works
Barst, R. J., Ivy, D. D., Gaitán, G. A., Szatmári, A., Rudziński, A., García, A. E., Sastry, B. K. S., Pulido, T., Layton, G. R., Serdarevic-Pehar, M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.016667 · Cited by 371 · see citing works
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
Wharton, J., Strange, J., Møller, G. M. O., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1587oc · Cited by 371 · see citing works
Rich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V. V., & Francis, G. S. (1998) · CHEST Journal · doi:10.1378/chest.114.3.787 · Cited by 370 · see citing works
Diastolic Pulmonary Vascular Pressure Gradient
Gerges, C., Gerges, M., Lang, M., Zhang, Y., Jakowitsch, J., Probst, P., Maurer, G., & Lang, I. M. (2013) · CHEST Journal · doi:10.1378/chest.12-1653 · Cited by 369 · see citing works
Self-citationKessler, R., Faller, M., Weitzenblum, E., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2006129 · Cited by 366 · see citing works
Nickel, N. P., Golpon, H. A., Greer, M., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00092311 · Cited by 366 · see citing works
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jaïs, X., Hervé, P., Garcia, G., Humbert, M. J. C., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 360 · see citing works
Self-citationGraded balloon dilation atrial septostomy in severe primary pulmonary hypertension
Sandoval, J., Gaspar, J., Pulido, T., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00238-1 · Cited by 356 · see citing works
Pulmonary Veno-Occlusive Disease
Montani, D., Achouh, L., Dorfmüller, P., Pavec, J. L., Sztrymf, B., Tchérakian, C., Rabiller, A., Haque, R. A., Sitbon, O., Jaïs, X., et al. (2008) · Medicine · doi:10.1097/md.0b013e31818193bb · Cited by 356 · see citing works
Self-citationA randomised, controlled trial of bosentan in severe COPD
Stolz, D., Rasch, H., Linka, A., Valentino, M. D., Meyer, A., Brutsche, M. H., & Tamm, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00011308 · Cited by 355 · see citing works
Barst, R. J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00005-5 · Cited by 350 · see citing works
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Guérin, L., Couturaud, F., Parent, F., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0538 · Cited by 349 · see citing works
Echocardiographic measurement of the normal adult right ventricle.
Foale, R., Nihoyannopoulos, P., McKenna, W. J., Kleinebenne, A., Nadazdin, A., Rowland, E., Smith, G. S., & Klienebenne, A. (1986) · Heart · doi:10.1136/hrt.56.1.33 · Cited by 349 · see citing works
Self-citationClinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Fisher, M. R., Mathai, S. C., Champion, H. C., Girgis, R. E., Housten-Harris, T., Hummers, L. K., Krishnan, J. A., Wigley, F. M., & Hassoun, P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22069 · Cited by 348 · see citing works
Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension
Sachdev, A., Villarraga, H. R., Frantz, R. P., McGoon, M. D., Hsiao, J., Maalouf, J. F., Ammash, N. M., McCully, R. B., Miller, F. A., Pellikka, P. A., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-2015 · Cited by 348 · see citing works
Severe Pulmonary Hypertension during Pregnancy
Bonnin, M., Mercier, F. J., Sitbon, O., et al. (2005) · Anesthesiology · doi:10.1097/00000542-200506000-00012 · Cited by 347 · see citing works
Sugimura, K., Fukumoto, Y., Satoh, K., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-1217 · Cited by 346 · see citing works
Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups
Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B. B., & Krowka, M. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02384.x · Cited by 338 · see citing works
Pediatric Pulmonary Hypertension in the Netherlands
van Loon, R. L. E., Roofthooft, M. T. R., Hillege, H. L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.969584 · Cited by 330 · see citing works
Avouac, J., AIRÒ, P., Meune, C., Beretta, L., Dieudé, P., Caramaschi, P., TIEV, K. P., Cappelli, S., Diot, É., Vacca, A., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100245 · Cited by 327 · see citing works
Self-citationRiociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction
Bonderman, D., Ghio, S., Felix, S. B., Ghofrani, H. A., Michelakis, E. D., Mitrović, V. L., Oudiz, R. J., Boateng, F., Scalise, A., Roessig, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001458 · Cited by 326 · see citing works
Self-citationJing, Z., Parikh, K. H., Pulido, T., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.124388 · Cited by 326 · see citing works
Miller, W. L., Grill, D. E., & Borlaug, B. A. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.05.001 · Cited by 322 · see citing works
Manes, A., Palazzini, M., Leci, E., Reggiani, M. L. B., Branzi, A., & Galiè, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht072 · Cited by 322 · see citing works
Self-citationTorbicki, A., Kurzyna, M., Kuca, P., Fijałkowska, A., Sikora, J., Florczyk, M., Pruszczyk, P., Burakowski, J., & Wawrzyńska, L. (2003) · Circulation · doi:10.1161/01.cir.0000084544.54513.e2 · Cited by 317 · see citing works
Self-citationNunès, H., Humbert, M., Sitbon, O., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-330oc · Cited by 317 · see citing works
Self-citationHoeper, M. M., & Granton, J. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0662ci · Cited by 316 · see citing works
Self-citationHoeper, M. M., Olschewski, H., Ghofrani, H. A., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00494-5 · Cited by 315 · see citing works
Self-citationSimonneau, G., Torbicki, A., Hoeper, M. M., Delcroix, M., Karlócai, K., Galiè, N., Degano, B., Bonderman, D., Kurzyna, M., Efficace, M., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00137511 · Cited by 313 · see citing works
Self-citationProvencher, S., Hervé, P., Jaïs, X., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.013 · Cited by 312 · see citing works
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
Naeije, R., Vachiéry, J., Yerly, P., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00074312 · Cited by 312 · see citing works
Robalino, B. D., & Moodie, D. S. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80121-4 · Cited by 302 · see citing works
HIV-Associated Primary Pulmonary Hypertension. A Case Control Study. Swiss HIV Cohort Study
Opravil, M., Pechère, M., Speich, R., Joller‐Jemelka, H. I., Jenni, R., Russi, E. W., Hirschel, B. J., & Luthy, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117037 · Cited by 298 · see citing works
Krowka, M. J., Miller, D. P., Barst, R. J., Taichman, D. B., Dweik, R. A., Badesch, D. B., & McGoon, M. D. (2011) · CHEST Journal · doi:10.1378/chest.11-0160 · Cited by 298 · see citing works
Tapson, V. F., Jing, Z., Xu, K., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-2875 · Cited by 298 · see citing works
Pulmonary Veno-occlusive Disease
Mandel, J., Mark, E. J., & Hales, C. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912045 · Cited by 296 · see citing works
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
Provencher, S., Sitbon, O., Humbert, M. J. C., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi728 · Cited by 296 · see citing works
Self-citationPulmonary veno-occlusive disease
Montani, D., Price, L., Dorfmüller, P., Achouh, L., Jaïs, X., Yaici, A., Sitbon, O., Musset, D., Simonneau, G., & Humbert, M. J. C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00090608 · Cited by 296 · see citing works
Self-citationResults of European post-marketing surveillance of bosentan in pulmonary hypertension
Humbert, M. J. C., Segal, E. S., Kiely, D. G., Carlsen, J., Schwierin, B., & Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00138706 · Cited by 294 · see citing works
Self-citationSafety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension
Tapson, V. F., Gomberg‐Maitland, M., McLaughlin, V. V., Benza, R. L., Widlitz, A. C., Krichman, A. D., & Barst, R. J. (2006) · CHEST Journal · doi:10.1378/chest.129.3.683 · Cited by 293 · see citing works
Treatment Goals of Pulmonary Hypertension
McLaughlin, V. V., Gaine, S., Howard, L., Leuchte, H. H., Mathier, M. A., Mehta, S., Palazzini, M., Park, M., Tapson, V. F., & Sitbon, O. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.034 · Cited by 293 · see citing works
Self-citationNagaya, N., Uematsu, M., Satoh, T., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9812078 · Cited by 292 · see citing works
Krowka, M. J., Frantz, R. P., McGoon, M. D., Severson, C. J., Plevak, D. J., & Wiesner, R. H. (1999) · Hepatology · doi:10.1002/hep.510300307 · Cited by 291 · see citing works
Blanco, I., Gimeno, E., Muñoz, P. A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-0988oc · Cited by 291 · see citing works
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958801 · Cited by 289 · see citing works
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
Dorfmüller, P., Zarka, V., Durand–Gasselin, I., Monti, G., Balabanian, K., Garcia, G., Capron, F., L’Herminé, A. C., Marfaing‐Koka, A., Simonneau, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288 · see citing works
Self-citationCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H. H., Halank, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 288 · see citing works
Self-citationGhofrani, H. A., Voswinckel, R., Reichenberger, F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.060 · Cited by 287 · see citing works
Clinical risk factors for portopulmonary hypertension†
Kawut, S. M., Krowka, M. J., Trotter, J. F., et al. (2008) · Hepatology · doi:10.1002/hep.22275 · Cited by 286 · see citing works
Paciocco, G., Martínez, F. J., Bossone, E., Pielsticker, E. J., Gillespie, B. W., & Rubenfire, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17406470 · Cited by 282 · see citing works
Pulmonary Pressures and Death in Heart Failure
Bursi, F., McNallan, S. M., Redfield, M. M., Nkomo, V. T., Lam, C. S. P., Weston, S. A., Jiang, R., & Roger, V. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.076 · Cited by 280 · see citing works
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
Tongers, J., Schwerdtfeger, B., Klein, G. G., Kempf, T., Schaefer, A., Knapp, J.-M., Niehaus, M., Korte, T., & Hoeper, M. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.09.008 · Cited by 279 · see citing works
Self-citationInhibition of Hypoxic Pulmonary Vasoconstriction by Nifedipine
Simonneau, G., Escourrou, P., Duroux, P., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042606 · Cited by 275 · see citing works
Self-citationCX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand–Gasselin, I., Capel, F., Bouchet‐Delbos, L., Portier, A., Marfaing‐Koka, A., Krzysiek, R., Rimaniol, A., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 273 · see citing works
Self-citationTrulock, E. P., Edwards, L. B., Taylor, D. O., Boucek, M. M., Keck, B. M., & Hertz, M. I. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.001 · Cited by 271 · see citing works
Quarck, R. A., Nawrot, T. S., Meyns, B. P., & Delcroix, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.038 · Cited by 270 · see citing works
Barberà, J. A., Roger, N., Roca, J., Rodriguez-Roisín, R., Rovira, I., & Higenbottam, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90011-2 · Cited by 269 · see citing works
Self-citationdel Cerro, M. J., Abman, S. H., Díaz, G., Freudenthal, A. H., Freudenthal, F. P., Harikrishnan, S., Haworth, S. G., Ivy, D. D., Lopes, A. A., Raj, J. U., et al. (2011) · Pulmonary Circulation · doi:10.4103/2045-8932.83456 · Cited by 268 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- [10]10. Ivy DD, Abman SH, Barst RJ, Berger RMF, Bonnet D, Fleming TR, Haworth SG, Raj JU, Rosenzweig EB, Schulze Neick I, Steinhorn RH, Beghetti M. Pediatric pul- monary hypertension. J Am Coll Cardiol 2013;62:D117 -D126.
- [36]36. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK. Primary pulmonary hyperten- sion: a national prospective study. Ann Intern Med 1987;107:216 -223.
- [93]93. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013;62:D92 -D99.
- [151]151. Galie `N, Hoeper M, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Klepetko W, Joendeau G, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society. Eur Heart J 2009;30:2493 -2537.
- [373]373. Humbert M, Maı ˆtre S, Capron F, Rain B, Musset D, Simonneau G. Pulmonary ede- ma complicating continuous intravenous prostacyclin in pulmonary capillary he- mangiomatosis. Am J Respir Crit Care Med 1998;157:1681 -1685.
- [424]424. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmon- ary hypertension. Circulation 2006;113:2011 -2020.
Cited by
Sorted by citations
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866 · see citing works
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813 · see citing works
Self-citation2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292 · see citing works
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958 · see citing works
Self-citationUpdate of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104 · see citing works
Self-citationRisk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819 · see citing works
Self-citationLeard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821 · see citing works
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676 · see citing works
Hoeper, M. M., Kramer, T., Pan, Z., Eichstaedt, C. A., Spiesshoefer, J., Benjamin, N., Olsson, K. M., Meyer, K., Vizza, C. D., Vonk-Noordegraaf, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00740-2017 · Cited by 660 · see citing works
Self-citationPredicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643 · see citing works
Tietjens, J. R., Claman, D., Kezirian, E. J., De Marco, T., Mirzayan, A., Sadroonri, B., Goldberg, A. N., Long, C., Gerstenfeld, E. P., & Yeghiazarians, Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010440 · Cited by 397 · see citing works
Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests
Topalovic, M., Das, N., Burgel, P.-R., Daenen, M., Derom, E., Haenebalcke, C., Janssen, R., Kerstjens, H. A. M., Liistro, G., Louis, R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01660-2018 · Cited by 238 · see citing works
Fanaroff, A. C., Califf, R. M., Windecker, S., Smith, S. C., & Lopes, R. D. (2019) · JAMA · doi:10.1001/jama.2019.1122 · Cited by 228 · see citing works
Self-citationHoeper, M. M., Benza, R. L., Corris, P., de Perrot, M., Fadel, E., Keogh, A. M., Kühn, C., Savale, L., & Klepetko, W. (2019) · European Respiratory Journal · doi:10.1183/13993003.01906-2018 · Cited by 216 · see citing works
Self-citationSachdeva, R., Valente, A. M., Armstrong, A. K., Cook, S. C., Han, B. K., Lopez, L., Lui, G. K., Pickard, S. S., Powell, A. J., Bhave, N. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.002 · Cited by 193 · see citing works
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186 · see citing works
Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography
Kwon, J.-M., Kim, K.-H., Medina-Inojosa, J., Jeon, K.-H., Park, J., & Oh, B.-H. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.04.009 · Cited by 108 · see citing works
Young, A., Vummidi, D., Visovatti, S., Homer, K., Wilhalme, H., White, E. S., Flaherty, K., McLaughlin, V., & Khanna, D. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40862 · Cited by 85 · see citing works
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.01587-2018 · Cited by 79 · see citing works
Olsson, K. M., Meltendorf, T., Fuge, J., Kamp, J. C., Park, D.-H., Richter, M. J., Gall, H., Ghofrani, H. A., Ferrari, P., Schmiedel, R., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667602 · Cited by 55 · see citing works
Self-citationYang, G., Wang, Y., Ma, A., & Wang, T. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1055-x · Cited by 51 · see citing works
Chakinala, M. M., Coyne, D. W., Benza, R. L., Frost, A. E., McGoon, M. D., Hartline, B. K., Frantz, R. P., Selej, M., Zhao, C., Mink, D. R., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.10.028 · Cited by 48 · see citing works
Badagliacca, R., Papa, S., Poscia, R., Valli, G., Pezzuto, B., Manzi, G., Torre, R., Gianfrilli, D., Sciomer, S., Palange, P., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.11.015 · Cited by 46 · see citing works
Nikitopoulou, I., Manitsopoulos, N., Kotanidou, A., Tian, X., Petrovic, A., Magkou, C., Ninou, I., Aidinis, V., Schermuly, R. T., Kosanovic, D., et al. (2019) · Pulmonary Circulation · doi:10.1177/2045894019881954 · Cited by 44 · see citing works
Self-citationKhawar, M. U., Yazdani, D., Zhu, Z., Jandarov, R., Dilling, D. F., & Gupta, N. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.015 · Cited by 45 · see citing works
Pathophysiology of Heart Failure with Preserved Ejection Fraction
Youn, J.-C., Ahn, Y., & Jung, H. O. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.02.001 · Cited by 45 · see citing works
Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension
Savale, L., Le Pavec, J., Mercier, O., Mussot, S., Jaïs, X., Fabre, D., O’Connell, C., Montani, D., Stephan, F., Sitbon, O., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.02.034 · Cited by 42 · see citing works
Self-citationAn electrocardiogram-based AI algorithm for early detection of pulmonary hypertension
DuBrock, H. M., Wagner, T. E., Carlson, K., Carpenter, C. L., Awasthi, S., Attia, Z. I., Frantz, R. P., Friedman, P. A., Kapa, S., Annis, J., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00192-2024 · Cited by 38 · see citing works
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Rysz-Górzynska, M., Gluba-Brzózka, A., Sahebkar, A., Serban, M.-C., Mikhailidis, D. P., Ursoniu, S., Toth, P. P., Bittner, V., Watts, G. F., Lip, G. Y. H., et al. (2016) · Scientific Reports · doi:10.1038/srep30060 · Cited by 33 · see citing works
Self-citationLower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
Cai, Z., Klein, T., Geenen, L. W., Tu, L., Tian, S., van den Bosch, A. E., de Rijke, Y. B., Reiss, I. K. M., Boersma, E., Duncker, D. J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051248 · Cited by 17 · see citing works
Winter, L., Naumann, F., Olsson, K., Fuge, J., Hoeper, M. M., & Kahl, K. G. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00143 · Cited by 12 · see citing works
Self-citationLee, J., & Song, J.-U. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e48 · Cited by 10 · see citing works
Indications for Lung Transplantation and Patient Selection
Son, J., & Shin, C. (2022) · Journal of Chest Surgery · doi:10.5090/jcs.22.057 · Cited by 9 · see citing works
Gebhardt, P., Caldarone, F., Westhoff-Bleck, M., Olsson, K. M., Hoeper, M. M., Park, D.-H., Stapel, B., Breitner, M. H., Werth, O., Heitland, I., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.812807 · Cited by 3 · see citing works
Self-citation
- Authors
- Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M. A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L. A., Trindade, P. T., Zompatori, M., Hoeper, M., ESC Scientific Document Group, Aboyans, V., Vaz Carneiro, A., Achenbach, S., Agewall, S., Allanore, Y., Asteggiano, R., Badano, L. P., Barberá, J. A., Bouvaist, H., Bueno, H., Byrne, R. A., Carerj, S., Castro, G., Erol, Ç., Falk, V., Funck-Brentano, C., Gorenflo, M., Granton, J., Iung, B., Kiely, D. G., Kirchhof, P., Kjellstrom, B., Landmesser, U., Lekakis, J., Lionis, C., Lip, G. Y. H., Orfanos, S. E., Park, M. H., Piepoli, M. F., Ponikowski, P., Revel, M.-P., Rigau, D., Rosenkranz, S., Völler, H., Zamorano, J. L., Zamorano, J. L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J. J., Bueno, H., Carerj, S., Dean, V., Erol, Ç., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G. Y., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A., Windecker, S., Myftiu, S., Bonderman, D., Firdovsi, I., Lazareva, I., De Pauw, M., Sokolovic, Š., Velchev, V., Cikeš, M., Moutiris, J. A., Jansa, P., Nielsen-Kudsk, J. E., Anton, L., Jääskeläinen, P., Bauer, F., Chukhrukidze, A., Opitz, C., Giannakoulas, G., Karlócai, K., Oddsson, H., Gaine, S., Menachemi, D., Emdin, M., Sooronbaev, T., Rudzitis, T. A., Gumbiene, L., Lebrun, F., Micallef, J., Botnaru, V., Oukerraj, L., Andreassen, A. K., Kurzyna, M., Leite Baptista, M. J. R., Coman, I. M., Moiseeva, O., Stefanovic, B. S., Šimková, I., Wikström, G., Schwerzmann, M., Srbinovska-Kostovska, E., van Dijk, A. P. J., Mahdhaoui, A., Kaymaz, C., Coghlan, G., & Sirenko, Y.
- Affiliations
- University of Bologna (IT)
- Université Paris-Sud (FR)
- ORCID
- Galiè, Nazzareno
- Humbert, Marc
- Lang, Irene
- Simonneau, Gérald
- Beghetti, Maurice
- Hansmann, Georg
- Klepetko, Walter
- Trindade, Pedro T.
- Hoeper, Marius
- Asteggiano, Riccardo
- Badano, Luigi Paolo
- Falk, Volkmar
- Iung, Bernard
- Kiely, David G
- Landmesser, Ulf
- Lionis, Christos
- Park, Myung H
- Revel, Marie-Pierre
- Bax, Jeroen J
- Kolh, Philippe
- Windecker, Stephan
- Giannakoulas, George
- Botnaru, Victor
- Kurzyna, Marcin
- Šimková, Iveta
- Coghlan, Gerry
- Sirenko, Yuriy
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-29
- Volume
- 37
- Issue
- 1
- Pages
- 67-119
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2161370807
- Cited by
- 6,931
- References
- 471
- Citations by year
- 2026: 174 · 2025: 297 · 2024: 408 · 2023: 560 · 2022: 778 · 2021: 953 · 2020: 930 · 2019: 794 · 2018: 801 · 2017: 659 · 2016: 461 · 2015: 65 · 2014: 34 · 2013: 6
- FWCI
- 524.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Respiratory Society
- European Society of Cardiology
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Epidemiology › Congenital Heart Disease Studies
- Keywords
- pulmonary hypertension, diagnosis, treatment, right ventricular function, pulmonary circulation, congenital heart disease, valvular heart disease, heart failure, pharmacotherapy, cardiovascular surgery
- MeSH terms
- Adult, Algorithms, Antihypertensive Agents, Arrhythmias, Cardiac, Child, Combined Modality Therapy, Connective Tissue Diseases, Cross Infection, Drug Interactions, Echocardiography, Electrocardiography, Exercise Test, Exercise Therapy, Female, Genetic Counseling, Genetic Testing, Health Status, Cardiac Catheterization, Heart Defects, Congenital, Hemangioma, Hemoptysis, Humans, Hypertension, Portal, Hypertension, Pulmonary, Patient Compliance, Pregnancy, Pregnancy Complications, Cardiovascular, Referral and Consultation, Respiratory Function Tests, Risk Factors, Social Support, Terminal Care, Thromboembolism, Tomography, X-Ray Computed, Biomarkers, HIV Infections, Lung Transplantation, Treatment Outcome, Elective Surgical Procedures, Ventricular Dysfunction, Right, Risk Assessment, Magnetic Resonance Angiography, Therapies, Investigational, Travel Medicine, Balloon Embolectomy, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
